Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Armata Pharmaceuticals (ARMP) Operating Expenses (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Operating Expenses for 6 consecutive years, with $2.8 million as the latest value for Q4 2018.

  • Quarterly Operating Expenses rose 17.15% to $2.8 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $11.1 million through Dec 2018, down 31.65% year-over-year, with the annual reading at $41.5 million for FY2025, 12.75% down from the prior year.
  • Operating Expenses hit $2.8 million in Q4 2018 for Armata Pharmaceuticals, up from $2.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $11.9 million in Q4 2016 to a low of $784000.0 in Q3 2017.
  • Historically, Operating Expenses has averaged $3.8 million across 5 years, with a median of $2.9 million in 2018.
  • Biggest five-year swings in Operating Expenses: skyrocketed 287.42% in 2016 and later crashed 79.93% in 2017.
  • Year by year, Operating Expenses stood at $2.7 million in 2014, then rose by 13.71% to $3.1 million in 2015, then surged by 287.42% to $11.9 million in 2016, then plummeted by 79.93% to $2.4 million in 2017, then increased by 17.15% to $2.8 million in 2018.
  • Business Quant data shows Operating Expenses for ARMP at $2.8 million in Q4 2018, $2.4 million in Q3 2018, and $2.8 million in Q2 2018.